We Want to Share Your Story With Eli Lilly

The AGSAA would like to collect testimonials and data ahead of our November 17th meeting with representatives from Eli Lilly’s medical, regulatory, and advocacy groups so that we can provide stories, testimonials, and numbers in an effort to educate them about the burden our community carries with respect to our only treatment, JAK inhibition.

We Have 4 ways that you can help